Pear Therapeutics, Inc. Reaffirms Revenue Guidance for the Year 2022 and Provides Revenue Guidance for the Year 2023
The company expects 2023 revenue in the range of $27 million to $37 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
23/05 | Pear Therapeutics, Inc. Went Out of Business | CI |
08/05 | Combined Liquidation Plan and Disclosure Statement Approved for Pear Therapeutics, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 142 | |
+43.36% | 5.46TCr | |
-5.31% | 3.99TCr | |
+14.75% | 2.69TCr | |
-12.56% | 2.62TCr | |
-22.45% | 1.88TCr | |
+25.12% | 1.22TCr | |
+0.04% | 1.22TCr | |
+26.04% | 1.19TCr | |
-11.83% | 1.07TCr |